We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In a previous blog post, I wrote about how soon after ...
Epioxa, an epithelium-on corneal collagen cross-linking therapy, made a significant and clinically meaningful difference in ...
On Monday, Glaukos Corporation (NYSE:GKOS) received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application (NDA) for ...
A study published in Ophthalmology and Therapy found that Epioxa, an epithelium-on corneal collagen cross-linking treatment, ...
(MASS APPEAL) – If you’ve been diagnosed with Keratoconus then Corneal Cross Linking might get you back to better eyesight. Mass Appeal’s Patrick Berry joined Dr. John P. Frangie, MD to learn more.
Keratoconus is a progressive corneal ectasia characterised by stromal thinning, anterior protrusion and irregular astigmatism leading to visual impairment. Corneal collagen crosslinking (CXL) has ...
(NAPSI)—There could be good news if you or someone you care about is ever among the one in 6,000 Americans the National Institutes of Health estimates will be diagnosed with keratoconus (KC). There is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results